Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Brain Sciences|May 6, 2020
Improving the Ability to Write Persuasive Texts in a Boy with Autism Spectrum Disorder: Outcomes of an InterventionSergio Melogno, Maria Antonietta Pinto, Andrea Ruzza, et al.Interactive Cardiovascular and Thoracic Surgery|April 26, 2013
Combined heart and kidney transplantation: what is the appropriate surgical sequence?Andrea Ruzza, Lawrence S C Czer, Alfredo Trento, et al.The Journal of Thoracic and Cardiovascular Surgery|November 9, 2013
Three hundred robotic-assisted mitral valve repairs: the Cedars-Sinai experienceDanny Ramzy, Alfredo Trento, Wen Cheng, et al.Cardiovascular Journal of Africa|October 22, 2014
Prevalence of hypertension in the Gambia and Sierra Leone, western Africa: a cross-sectional studyMorcos Awad, Andrea Ruzza, James Mirocha, et al.Journal of Clinical Lipidology|November 9, 2021
Evolocumab in patients with homozygous familial hypercholesterolemia in IndiaSandeep Bansal, Andrea Ruzza, Jps Sawhney, et al.Texas Heart Institute Journal|December 21, 2017
Left Ventricular Reconstruction for Postinfarction Left Ventricular Aneurysm: Review of Surgical TechniquesAndrea Ruzza, Lawrence S C Czer, Francisco Arabia, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|April 4, 2017
One-Year Efficacy and Safety of Evolocumab in Japanese Patients - A Pooled Analysis From the Open-Label Extension OSLER StudiesAtsushi Hirayama, Shizuya Yamashita, Hyoe Inomata, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|April 2, 2019
Long-Term Treatment With Evolocumab Among Japanese Patients - Final Report of the OSLER Open-Label Extension StudiesAtsushi Hirayama, Shizuya Yamashita, Andrea Ruzza, et al.Cardiovascular Drugs and Therapy|August 4, 2018
Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension StudiesLeslie Cho, Ricardo Dent, Erik S G Stroes, et al.Journal of Clinical Lipidology|October 16, 2018
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT studyDaniel Gaudet, Gisle Langslet, Samuel S Gidding, et al.Pageof 3